Hims & Hers Health (HIMS) Other Non-Current Assets (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Other Non-Current Assets came in at $47.6 million in Q1 2026, up 3794.11% year-on-year from $1.2 million in Q1 2025, and up 60.46% quarter-over-quarter from $29.7 million in Q4 2025.
Hims & Hers Health (HIMS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $47.6 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $47.6 million, up 3794.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.6 million (up 3794.11% YoY), and the FY2025 annual result was $29.7 million, up 3367.29% from the prior year.
- Other Non-Current Assets came in at $47.6 million for Q1 2026 at Hims & Hers Health, up from $29.7 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $47.6 million in Q1 2026 to a low of $856000.0 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $856000.0 (2022), against an average of $5.6 million.
- Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and jumped 3794.11% in 2026, its largest moves.
- Hims & Hers Health's Other Non-Current Assets stood at $856000.0 in 2022, then changed by 0.0% to $856000.0 in 2023, then changed by 0.0% to $856000.0 in 2024, then jumped by 3367.29% to $29.7 million in 2025, then surged by 60.46% to $47.6 million in 2026.
- The last three Other Non-Current Assets figures came in at $47.6 million (Q1 2026), $29.7 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 3.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.63 Mn |
| Dec 31, 2025 | 29.68 Mn |
| Sep 30, 2025 | 3.88 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Dec 31, 2024 | 856,000.00 |
| Sep 30, 2024 | 856,000.00 |
| Jun 30, 2024 | 856,000.00 |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | 856,000.00 |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 856,000.00 |
| Mar 31, 2023 | 856,000.00 |
| Dec 31, 2022 | 856,000.00 |
| Sep 30, 2022 | 856,000.00 |
| Jun 30, 2022 | 856,000.00 |
| Mar 31, 2022 | 856,000.00 |
| Dec 31, 2021 | 856,000.00 |
| Sep 30, 2021 | 856,000.00 |
| Jun 30, 2021 | 856,000.00 |